BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21194632)

  • 1. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
    Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
    J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.
    Benítez J; Guggeri L; Tomaz I; Arrambide G; Navarro M; Pessoa JC; Garat B; Gambino D
    J Inorg Biochem; 2009 Apr; 103(4):609-16. PubMed ID: 19091422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and anti-tumor agent.
    Benítez J; Guggeri L; Tomaz I; Pessoa JC; Moreno V; Lorenzo J; Avilés FX; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1386-94. PubMed ID: 19695708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
    Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
    Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
    Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
    J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents.
    Fernández M; Becco L; Correia I; Benítez J; Piro OE; Echeverria GA; Medeiros A; Comini M; Lavaggi ML; González M; Cerecetto H; Moreno V; Pessoa JC; Garat B; Gambino D
    J Inorg Biochem; 2013 Oct; 127():150-60. PubMed ID: 23528424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
    Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
    J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
    Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
    J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
    Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
    Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives.
    Gómez-Ayala S; Castrillón JA; Palma A; Leal SM; Escobar P; Bahsas A
    Bioorg Med Chem; 2010 Jul; 18(13):4721-39. PubMed ID: 20627590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents.
    Vieites M; Otero L; Santos D; Toloza J; Figueroa R; Norambuena E; Olea-Azar C; Aguirre G; Cerecetto H; González M; Morello A; Maya JD; Garat B; Gambino D
    J Inorg Biochem; 2008; 102(5-6):1033-43. PubMed ID: 18226837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.
    Reimão JQ; Scotti MT; Tempone AG
    Bioorg Med Chem; 2010 Nov; 18(22):8044-53. PubMed ID: 20934347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One pot synthesis of Cu(II) 2,2'-bipyridyl complexes of 5-hydroxy-hydurilic acid and alloxanic acid: synthesis, crystal structure, chemical nuclease activity and cytotoxicity.
    Dixit N; Koiri RK; Maurya BK; Trigun SK; Höbartner C; Mishra L
    J Inorg Biochem; 2011 Feb; 105(2):256-67. PubMed ID: 21194626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
    Moreno V; Font-Bardia M; Calvet T; Lorenzo J; Avilés FX; Garcia MH; Morais TS; Valente A; Robalo MP
    J Inorg Biochem; 2011 Feb; 105(2):241-9. PubMed ID: 21194624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
    Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
    Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
    León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
    J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
    da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
    Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.
    Ramakrishnan S; Rajendiran V; Palaniandavar M; Periasamy VS; Srinag BS; Krishnamurthy H; Akbarsha MA
    Inorg Chem; 2009 Feb; 48(4):1309-22. PubMed ID: 19140687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of the anti parasitic activity of aromatic nitro compounds.
    Lopes MS; de Souza Pietra RC; Borgati TF; Romeiro CF; Júnior PA; Romanha AJ; Alves RJ; Souza-Fagundes EM; Fernandes AP; de Oliveira RB
    Eur J Med Chem; 2011 Nov; 46(11):5443-7. PubMed ID: 21940071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
    Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
    Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.